Death deflected: IL-15 inhibits TNF-α-mediated apoptosis in fibroblasts by TRAF2 recruitment to the IL-15Rα chain

FASEB Journal

Volumn 13, Issue 12, 1999, Pages 1575-1585

  Bulfone Paus, Silvia ^a   Bulanova, Elena ^a   Pohl, Thomas ^a   Budagian, Vadim ^a   Dürkop, Horst ^a   Rückert, René ^a   Kunzendorf, Ulrich ^b   Paus, Ralf ^c   Krause, Hans ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c Free University Berlin ^*

Author keywords

Cell death; I B; L929; TNFR1

Indexed keywords

INTERLEUKIN 15; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; BINDING SITE; CELL DEATH; FIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION;

ANIMALIA; MURINAE;

EID: 0032876816     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fasebj.13.12.1575     Document Type: Article

References (55)

1. Grabstein, K. H., Eisenman, J., Shanebeck, K., Rauch, C., Srinivasan, S., Fung, V., Beers, C., Richardson, J., Schoenborn, M. A., Ahdieh, M., et al. (1994) Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science 264, 965-968
2. Bamford, R. N., Grant, A. J., Burton, J. D., Peters, C., Kurys, G., Goldman, C. K., Brennan, J., Roessler, E., and Waldmann, T. A. (1994) The interleukin (IL) 2 receptor beta chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc. Natl. Acad. Sci. USA 91, 4940-4944
3. Giri, J. G., Ahdieh, M., Eisenman, J., Shanebeck, K., Grabstein, K., Kumaki, S., Namen, A., Park, L. S., Cosman, D., and Andersen, D. (1994) Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J. 13, 2822-2830
4. Tagaya, Y., Bamford, R. N., DeFilippis, A. P., and Waldmann, T. A. (1996) IL-15: a pleiotropic cytokine with diverse receptor/ signaling pathways whose expression is controlled at multiple levels. Immunity 4, 329-336
5. Anderson, D. M., Kumaki, S., Ahdieh, M., Bertles, J., Tometsko, M., Loomis, A., Giri, J., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., Valentine, V., Shapiro, D. N., Morris, S. W., Park, L. S., and Cosman, D. (1995) Functional characterization of the human interleukin-15 receptor a chain and close linkage of IL15RA and IL2RA genes. J. Biol. Chem. 270, 29862-29869
6. Carson, W. E., Giri, J. G., Lindemann, M. J., Linett, M. L., Ahdieh, M., Paxton, R., Anderson, D., Eisenmann, J., Grabstein, K., and Caligiuri, M. A. (1994) Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J. Exp. Med. 180, 1395-1403
7. Giri, J. G., Kumaki, S., Ahdieh, M., Friend, D. J., Loomis, A., Shanebeck, K., DuBose, R., Cosman, D., Park, L. S., and Anderson, D. M. (1995) Identification and cloning of a novel IL-15 binding protein that is structurally related to the alpha chain of the IL-2 receptor. EMBO J. 14, 3654-3663
8. Armitage, R. J., Macduff, B. M., Eisenman, J., Paxton, R., and Grabstein, K. H. (1995) IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation. J. Immunol. 154, 483-490
9. Bulfone-Paus, S., Dürkop, H., Paus, R., Krause, H., Pohl, T., and Onu, A. (1997) Differential regulation of human T lymphoblast functions by IL-2 and IL-15. Cytokine 9, 507-513
10. Di Santo, J. (1997) Shared receptors, distinct functions. Curr. Biol. 7, R424-R426
11. Onu, A., Pohl, T., Krause, H., and Bulfone-Paus, S. (1997) Regulation of IL-15 secretion via the leader peptide of two IL-15 isoforms. J. Immunol. 158, 255-262
12. Bulfone-Paus, S., Ungureanu, D., Pohl, T., Lindner, G., Paus, R., Rücken, R., Krause, H., and Kunzendorf, U. (1997) Interleukin-15 protects from lethal apoptosis in vivo. Nature Med. 3, 1124-1128
13. Lindner, G., Rückert, R., Bulfone-Paus, S., and Paus, R. (1998) Inhibition of chemotherapy-induced keratinocyte apoptosis in vivo by an interleukin-15-IgG fusion protein (letter) J. Invest. Dermatol. 141, 101-102
14. Itoh N, and Nagata S. (1993) A novel protein domain required for apoptosis: mutational analysis of human Fas antigen. J. Biol. Chem. 268, 10932-10937
15. Tartaglia, L. A., Ayres, T. M., Wong, G. H., and Goeddel, D. V. (1993) A novel domain within the 55 kD TNF receptor signals cell death. Cell 74, 845-853
16. Tartaglia, L. A., Rothe, M., Hu, Y. F., and Goeddel, D. V. (1993) Tumor necrosis factor's cytotoxic activity is signaled by the p55 TNF receptor. Cell 73, 213-216
17. Nagata, S., and Suda T. (1995) Fas and Fas ligand: lpr and gld mutations. Immunol. Today 16, 39-43
18. Wallach, D. (1997) Cell death induction by TNF: a matter of self control. Trends. Biochem. Sci. 22, 107-109
19. Wallach, D. (1997) Placing death under control. Nature (London) 388, 123-126
20. Nagata, S. (1997) Apoptosis by death factor. Cell 88, 355-365
21. Chinnaiyan, A. M., O'Rourke, K., Yu, G. L., Lyons, R. H., Garg, M., Duan, D. R., Xing, L., Gentz, R., Ni, J., and Dxit, V. M. (1996) Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science 264, 707-710
22. Kitson, j., Raven, T., Jiang, Y. P., Goeddel, D., Giles, K. M., Pun, K. T., Grinham, C. J., Brown, R., and Farrow, S. N. (1996) A death domain-containing receptor that mediates apoptosis. Nature (London) 384, 372-375
23. Marsters, S. A., Sheridan, J. P., Donahue, C. J., Pitti, R. M., Gray, C. L., Goddard, A. D., Bauer, K. D., and Ashkenazi, A. (1996) Apo-3, a new member of the tumor necrosis factor receptor family, contains a death domain and activates apoptosis and NF-κB. Curr. Biol. 6, 1669-1676
24. Hsu, H., Xiong, J., and Goeddel, D. V. (1995) The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation. Cell 81, 495-504
25. Hsu, H., Shu, H. B., Pan, M. G., and Goeddel, D. V. (1996b) TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84, 299-308
26. Boldin, M. P., Varfolomeev, E. E., Pancer, Z., Mett, I. L., Camonis, J. H., and Wallach, D. (1995) A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J Biol. Chem. 270, 7795-7798
27. Chinnaiyan, A. M., O'Rourke, K., Tewari, M., and Dixit, V. M. (1995) FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81, 505-512
28. Stanger, B. Z., Leder, P., Lee, T. H., Kim, E., and Seed, B. (1995) RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell81, 513-523
29. Hsu, H., Huang, J., Shu, H. B., Baichwal, V., and Goeddel, D. V. (1996) TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity 4, 387-396
30. Baker, S. J., and Reddy, E. P. (1996) Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene 12, 1-9
31. Rothe, M., Wong, S. C., Henzel, W. J., and Goeddel, D. V. (1994) A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell 78, 681-692
32. Beg, A. A., and Baltimore, D. (1996) An essential role for NF-κB in preventing TNF-α-induced cell death. Science 274, 782-784
33. Wang, C-Y., Mayo, M. W., and Baldwin, A. S., Jr. (1996) TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science 274, 784-787
34. Van Antwerp, D. J., Martin, S. J., Kafri, T., Green, D. R., and Verma, I. M. (1996) Suppression of TNF-α-induced apoptosis by NF-κB. Science 274, 787-789
35. Liu, Z., Hsu, H., Goeddel, D. V., and Karin, M. (1996) Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell 87, 565-576
36. Cleveland, J. L., and Ihle, J. N. (1995) Contenders in FasL/TNF death signaling. Cell 81, 479-482
37. Fraser, A., and Evan, G. (1996) A license to kill. Cell 85, 781-784
38. Jacobson, M. D., Weil, M., and Raff, M. C. (1997) Programmed cell death in animal development. Cell 88, 347-354
39. White, E. (1996) Life, death, and the pursuit of apoptosis. Genes Dev. 10, 1-15
40. Tartaglia, L. A., and Goeddel, D. V. (1992) Two TNF receptors. Immunol. Today 13, 151-153
41. Xie, K., Huang, S., Dong, Z., and Fidler, I. J. (1993) Cytokine-induced apoptosis in transformed murine fibroblasts involves synthesis of endogenous nitric oxide. Int. J. Oncol. 3, 1043-1048
42. Coligan, J. E., Kruisbeek, A. M., Margulies, D. H., Shevach, E. M., and Strober, W. (1994) Current Protocols in Immunology, Wiley & Sons, Inc., New York
43. Kunzendorf, U., Pohl, T., Bulfone-Paus, S., Krause, H., Notter, M., Onu, A., Walz, G., and Diamantstein, T. (1996) Suppression of cell-mediated and humoral immune responses by an interleukin-2-immunoglobulin fusion protein in mice. J. Clin. Invest. 97, 1204-1210
44. Nicoletti, I., Migliorati, G., Pagliacci, M. C., Grignani, F., and Riccardi, C. (1991) A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol Methods 139, 271-279
45. Lewis, M., Tartaglia, L. A., Lee, A., Bennet, G. L., Rice, G. C., Wong, G. H. W., Chen, E. Y., and Goeddel, D. V. (1991) Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific. Proc. Natl. Acad. Sci. USA 88, 2830-2834
46. Kelliher, M, A., Grimm, S., Ishida, Y, Kuo, F., Stanger, B. Z., and Leder P. (1998) The death domain kinase RIP mediates the TNF-induced NF-κB signal. Immunity 8, 297-303
47. Boucher, L.M, Marengere, L. E. M., Lu, Y., Thukral, S., and Mak, T. W. (1997) Binding sites of cytoplasmic effectors TRAF1, 2, and 3 on CD30 and other members of the TNF receptor superfamily. Biochem. Biophy. Res. Commun. 233, 592-600
48. Baldwin, A. S. (1996) The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol. 14, 649-681
49. Baeuerle, P. A., and Baltimore, D. (1989) A 65-kD subunit of active NF-KB is required for inhibition of NF-B by IB. Genes Dev. 3, 1689-1698
50. Baichwal, V. R., and Baeuerle, P. A. (1997) Activate NF-κB or die? Curr. Biol. 7, R94-R96
51. Ghosh, S., May, M. J., and Kopp, E. B. (1998) NF-κB and REL proteins: evolutionary conserved mediators of immune responses. Annu. Rev. Immunol. 16, 225-260
52. Girard, D., Paquet, M. E., Paquin, R., and Beaulieu, D. (1996) Differential effects of interleukin-15 (IL-15) and IL-2 on human neutrophils: modulation of phagocytosis, cytoskeleton rearrangement, gene expression and apoptosis by IL-15. Blood 88, 3176-3184
53. Duckett, C. S., and Thompson, C. B. (1997) CD30-dependent degradation of TRAF2: implications for negative regulation of TRAF signaling and the control of cell survival. Genes Dev. 11, 2810-2821
54. Jacobson, M. D. (1998) Anti-apoptosis therapy: a way of treating neural degeneration? Curr. Biol. 8, R418-R422
55. Thompson, C. B. (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267, 1456-1462